久久久久免费_精品国产乱码久久久久久久软件_欧美一区亚洲一区_国产一区二区三区高清在线观看_欧美日在线观看_成人网av

意大利索林集團Sorin Group 
一家意大利致力于醫(yī)療技術(shù)領(lǐng)域的跨國公司，它最近宣布將推出一種在其種類中堪稱革命性的人工心臟瓣膜。一種能不打開胸部或停止心臟而被植入患者的產(chǎn)品。所以簡而言之，或許不必實施外科縫合術(shù)。這是一種生物學(xué)支持結(jié)構(gòu)的瓣膜，由于它利用了其它的醫(yī)療技術(shù)大約有十年，其基本概念已經(jīng)得到完善并經(jīng)過試驗。很長的孵化期使之能科學(xué)地展示其可靠性，現(xiàn)在對之已經(jīng)不再有疑義了。

Sorin Group is a global company and a leader in the treatment of cardiovascular diseases. The Company develops, manufactures and markets medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders.
The Group focuses on three major therapeutic areas that include: cardiopulmonary bypass (extracorporeal circulation and autotransfusion systems), cardiac rhythm management, and heart valve repair and replacement. Every year, over 1 million patients are treated with the devices of Sorin Group in more than 80 countries.